BD BBL Sensi-Disc Lefamulin 20µg (LMU-20)
K-Number: K230651 · 2023-06-07
Device Summary
Frequently Asked Questions
What is the BD BBL Sensi-Disc Lefamulin 20µg (LMU-20)?
BD BBL Sensi-Disc Lefamulin 20µg (LMU-20) is a medical device that received FDA 510(k) clearance on 2023-06-07. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K230651.
When was BD BBL Sensi-Disc Lefamulin 20µg (LMU-20) approved by the FDA?
BD BBL Sensi-Disc Lefamulin 20µg (LMU-20) received FDA 510(k) clearance on 2023-06-07, under approval number K230651.
What company makes BD BBL Sensi-Disc Lefamulin 20µg (LMU-20)?
BD BBL Sensi-Disc Lefamulin 20µg (LMU-20) is manufactured by Becton, Dickinson and Company.
What is the FDA product code for BD BBL Sensi-Disc Lefamulin 20µg (LMU-20)?
The FDA product code for BD BBL Sensi-Disc Lefamulin 20µg (LMU-20) is JTN.
Related PubMed Literature
Other Devices by Becton, Dickinson and Company
Related Devices (Code: JTN)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.